Abbott Files New Simcor Patent Suit Against Teva
Abbott and Abbott Respiratory LLC filed their complaint in the U.S. District Court for the District of Delaware, over Teva's bid for U.S. Food and Drug Administration approval to market a generic version of Simcor, which contains niacin and simvastatin.
Abbott sued Teva three times in 2010 over Simcor. However, Monday's suit references Teva's bid for a...
To view the full article, register now.